Ulrich Budde

12.9k citations

219 papers · 7.0k indexed · h-index 50

Impact in

Hematology top 0.1%
- Platelet Disorders and Treatments
- Blood groups and transfusion
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Blood disorders and treatments

Papers in

Hematology 186
- Platelet Disorders and Treatments 174
- Blood groups and transfusion 81
Genetics 53
- Blood disorders and treatments 43
- Myeloproliferative Neoplasms: Diagnosis and Treatment 25
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 19

Co-authors: Reinhard Schneppenheim Jan Michiels Tobias Obser Augusto B. Federici Sonja Schneppenheim Jacob H. Rand Andreas Tiede Perry J.J. van Genderen
Journals: Blood (25 papers)Thrombosis and Haemostasis (21 papers)Journal of Thrombosis and Haemostasis (19 papers)Seminars in Thrombosis and Hemostasis (12 papers)Haemophilia (9 papers)
Partner nations: Germany United States Italy

In The Last Decade

Ulrich Budde

218 papers receiving 6.8k citations

Peers

Countries citing papers authored by Ulrich Budde

Since Specialization

Citations

This map shows the geographic impact of Ulrich Budde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Budde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Budde more than expected).

Fields of papers citing papers by Ulrich Budde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Budde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Budde. The network helps show where Ulrich Budde may publish in the future.

Co-authors

The 25 scholars most cited alongside Ulrich Budde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulrich Budde Line = papers co-authored together Ulrich Budde links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019 Critical Care Medicine ·Adrian Doevelaar, Martin Bachmann, Bodo Hölzer, Felix S. Seibert, Benjamin Rohn, Frederic Bauer, Oliver Witzke, Ulf Dittmer, Michael H. Bachmann, Serap Yılmaz, Rita Dittmer, Sonja Schneppenheim, Nina Babel, Ulrich Budde, Timm H. Westhoff	2021	41
2	Ex vivo human placental transfer study on recombinant Von Willebrand factor (rVWF) Placenta ·Jana Pastuschek, C Bär, Claudia Göhner, Ulrich Budde, Peter Leidenmuehler, Tanja Groten, E Schleußner, Udo R. Markert	2021	3
3	Generalisierter Krampfanfall während der Anlage einer axillären Plexusblockade Der Anaesthesist ·Thomas Hillermann, K. Homburg, M. Rainer, Ulrich Budde	2021	0
4	Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms Blood Advances ·Ashley Cartwright, Simon J. Webster, Annika de Jong, Richard Dirven, Lisa D.S. Bloomer, Ahlam Al-buhairan, Ulrich Budde, Christer Halldén, David Habart, Jenny Goudemand, I. R. Peake, Jeroen Eikenboom, Anne Goodeve, Daniel J. Hampshire	2020	7
5	An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS‐VWF study Journal of Thrombosis and Haemostasis ·Attila Szederjesi, Luciano Baronciani, Ulrich Budde, Giancarlo Castaman, Andrew Lawrie, Y. Liu, Robert R. Montgomery, Flora Peyvandi, Reinhard Schneppenheim, Andrea Várkonyi, J. Patzke, Imre Bodó	2018	12
6	Update on von Willebrand factor multimers Blood Coagulation & Fibrinolysis ·Marcus Stockschlaeder, Reinhard Schneppenheim, Ulrich Budde	2014	163
7	VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease Blood ·Jeroen Eikenboom, Augusto B. Federici, Richard Dirven, Giancarlo Castaman, Francesco Rodeghiero, Ulrich Budde, Reinhard Schneppenheim, Javier Batlle, Maria Teresa Canciani, Jenny Goudemand, I. R. Peake, Anne Goodeve, (unknown)	2013	84
8	Deep intronic ‘mutations’ cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA Journal of Thrombosis and Haemostasis ·Behnaz Pezeshkpoor, N. Zimmer, N. Marquardt, I. Nanda, Thomas Haaf, Ulrich Budde, Johannes Oldenburg, Osman El‐Maarri	2013	59
9	Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort Thrombosis and Haemostasis ·Adel Abuzenadah, Ashley Cartwright, Nawal S. Alshammari, Rachael Coyle, Michaela Eckert, Ahlam Al-buhairan, Sarah L. Messenger, Ulrich Budde, Türkiz Gursel, Jørgen Ingerslev, I. R. Peake, Anne Goodeve, Daniel J. Hampshire	2013	7
10	Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura Haematologica ·R. Froehlich-Zahnd, JN George, Sara K. Vesely, Deirdra R. Terrell, Khatira Aboulfatova, Jing Dong, Brenda M. Luken, Jan Voorberg, Ulrich Budde, Irmela Sulzer, Bernhard Lämmle, Johanna A. Kremer Hovinga	2011	55
11	von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein Journal of Thrombosis and Haemostasis ·Reinhard Schneppenheim, Ulrich Budde	2011	66
12	Regulation der primären Hämostase durch von-Willebrand-Faktor und ADAMTS13 Hämostaseologie ·Ulrich Budde, Reinhard Schneppenheim	2011	3
13	Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas Journal of Thrombosis and Haemostasis ·C. A. LEE, A. R. Hubbard, Caroline Sabin, Ulrich Budde, Giancarlo Castaman, Emmanuel J. Favaloro, Kenneth D. Friedman, Augusto B. Federici	2010	8
14	Accelerated clearance alone explains ultra‐large multimers in von Willebrand disease Vicenza Journal of Thrombosis and Haemostasis ·András Gézsi, Ulrich Budde, István Deák, Eszter Nagy, Adrienn Mohl, Ágota Schlammadinger, Z Boda, Tamás Masszi, J. Evan Sadler, Imre Bodó	2010	19
15	Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease☆ European Journal of Cardio-Thoracic Surgery ·Ulrich Geisen, Claudia Heilmann, Friedhelm Beyersdorf, Christoph Benk, Michael Berchtold‐Herz, Christian Schlensak, Ulrich Budde, Barbara Zieger	2008	259
16	A common 253‐kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3 Journal of Thrombosis and Haemostasis ·Reinhard Schneppenheim, Giancarlo Castaman, Augusto B. Federici, W. Kreuz, Rolf Marschalek, Johannes Oldenburg, Florian Oyen, Ulrich Budde	2007	28
17	Dissecting the molecular mechanism of ADAMTS13 deficiency by expression of recombinant protein Reinhard Schneppenheim, Tobias Obser, Ulrich Budde	2003	1
18	The Thrombostat 4000 A Sensitive Screening Test for von Willebrand's Disease Seminars in Thrombosis and Hemostasis ·M. Weippert-Kretschmer, Michaele Witte, Ulrich Budde, Thomas Vigh, Kretschmer Volker, Inge Scharrer	1995	12
19	von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. Journal of Clinical Investigation ·Lars Holmberg, Judith Dent, Reinhard Schneppenheim, Ulrich Budde, Jerry Ware, Z M Ruggeri	1993	61
20	Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. Journal of Clinical Investigation ·Luigi De Marco, Mario Mazzuccato, Max Ben, Ulrich Budde, Augusto B. Federici, Antonio Girolami, Z M Ruggeri	1987	43

About Ulrich Budde

Ulrich Budde is a scholar working on Hematology, Genetics, Immunology, Nephrology and Genetics, having authored 219 papers that have together received 7.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (174 papers), Blood groups and transfusion (81 papers), Complement system in diseases (66 papers), Blood disorders and treatments (43 papers), Heparin-Induced Thrombocytopenia and Thrombosis (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers), Renal Diseases and Glomerulopathies (23 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). The work is most often cited by research in Hematology (4.8k citations), Genetics (1.6k citations), Nephrology (581 citations), Immunology (1.7k citations) and Internal Medicine (242 citations). Ulrich Budde has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Reinhard Schneppenheim, Jan Michiels, Tobias Obser, Augusto B. Federici, Sonja Schneppenheim, Jacob H. Rand, Andreas Tiede, Perry J.J. van Genderen, ZM Ruggeri and Axel Haverich. Their work appears in journals such as Blood, Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis, Seminars in Thrombosis and Hemostasis and Haemophilia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact